Free tool
Stocks near their 52-week high
We cover 97 companies trading within 5% of their own 52-week high. The median market value in the group is $1.63B. Across the group, the median move over the past trading day is 0.00%. 99% of the 92 with a 200-day average trade above it. Price change over the past year runs from +18.6% to +260.6% across the middle 80 percent of the group, with a median of +74.2%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
97 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.58B | Small cap | +298.89% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| SPTX | Seaport Therapeutics, Inc. | $1.49B | Small cap | +40.32% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| CRON.TO | Cronos Group Inc. | $1.31B | Small cap | +39.83% |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | $1.08B | Small cap | +35.66% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| B2RK34.SA | Bruker Corporation | $906.52M | Small cap | +63.27% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% |
| OABI | OmniAb, Inc. | $699.33M | Small cap | +198.76% |
| GUD.TO | Knight Therapeutics Inc. | $690.78M | Small cap | +50.39% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% |
| KSI.TO | kneat.com, inc. | $452.27M | Small cap | +19.93% |
| FRX.TO | Fennec Pharmaceuticals Inc. | $429.52M | Small cap | +36.00% |
| TBRG | TruBridge Inc | $393.58M | Small cap | +30.42% |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% |
| RCEL | AVITA Medical, Inc. | $327.52M | Small cap | +133.77% |
| SMTI | Sanara MedTech Inc. | $318.55M | Small cap | +2.09% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% |
| ORMP | Oramed Pharmaceuticals Inc. | $218.55M | Small cap | +159.19% |
| ASRT | Assertio Holdings Inc | $151.86M | Small cap | +103.46% |
| EMPG | Empro Group Inc | $143.05M | Small cap | +76.60% |
| LOVE.TO | Cannara Biotech Inc. | $141.63M | Small cap | +11.80% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% |
| A2ZT34.SA | Azenta, Inc. | $120.48M | Small cap | +50.80% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| APS.TO | Aptose Biosciences Inc | $4.41M | Micro cap | +50.00% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.